1. Cone M, Walker S. Building Quality Into Regulatory Dossiers and the Review Process: ‘Knowing and Meeting Customer Expectations’. Workshop report. Surrey, UK: CMR International Institute; 2005.
2. Cone M, McAuslane N. Building Quality Into Regulatory Activities: What Does It Mean? Epsom, UK: CMR International; 2006. R&D Briefing 46.
3. Hirako M, McAuslane N, Salek S, Anderson C, Walker S. A comparison of the drug review process at five international regulatory agencies. Drug Inf J. 2007;41: 291–308.
4. Anderson C. An Evaluation of Harmonisation in the Regulatory Environment and Its Impact on Patients’ Access to New Medicines [doctor of philosophy thesis]. Cardiff, Wales: University of Wales; 2004.
5. Hashan H. Evaluation of the Review Process for Marketing Pharmaceutical Products in the Gulf States and Its Impact on Patients’ Access to Medicines [doctor of philosophy thesis]. Cardiff, Wales: University of Wales; 2005.